Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» AbbVie
AbbVie
AbbVie's Ubrelvy wards off migraines when used in reaction to early warning signs: study
Fierce Pharma
Thu, 08/29/24 - 06:06 pm
AbbVie
Ubrelvy
migraines
clinical trials
Cigna to remove AbbVie's Humira from some drug reimbursement lists next year
Reuters
Mon, 08/26/24 - 10:14 pm
AbbVie
Humira
biosimilars
Cigna
reimbursement
BMS’ KarXT nears schizophrenia approval, but AbbVie and others wait in the wings
Pharma Voice
Mon, 08/19/24 - 09:58 am
Bristol Myers Squibb
KarXT
FDA
schizophrenia
AbbVie
Skyrizi soars to top of Rx, OTC pharma brand rankings in July
Medical Marketing and Media
Tue, 08/13/24 - 11:25 am
Skyrizi
AbbVie
television ads
Sandoz lifts guidance after Humira biosimilar drives another quarter of sales growth
Fierce Pharma
Fri, 08/9/24 - 11:25 am
Sandoz
earnings
biosimilars
Humira
AbbVie
Novartis
Pharma execs react to final drug price negotiations with Medicare
Pharma Voice
Fri, 08/9/24 - 11:21 am
Medicare
drug pricing
Inflation Reduction Act
Bristol Myers Squibb
Eli Lilly
JNJ
Bayer
Merck
AstraZeneca
Novartis
Amgen
AbbVie
Novo Nordisk
Market share shakeup: Big Pharma’s bestselling drugs drive industry shifts in 2024’s first half
Pharma Voice
Thu, 08/8/24 - 11:07 am
Big Pharma
JNJ
AbbVie
Pfizer
Roche
Eli Lilly
Novo Nordisk
Merck
Big Pharma-Backed Ribon Therapeutics Shuts Down Business Operations
BioSpace
Mon, 08/5/24 - 11:21 am
Ribon Therapeutics
AbbVie
JNJ
Novartis
Pfizer
PARP inhibitors
AbbVie Completes Acquisition Of Cerevel; Reaffirms Full-year Adj. EPS Guidance Range
NASDAQ
Thu, 08/1/24 - 11:52 am
AbbVie
Cerevel
M&A
AbbVie’s Skyrizi Wins EU Nod for Ulcerative Colitis, Helps to Weather Humira Patent Cliff
BioSpace
Mon, 07/29/24 - 10:31 am
AbbVie
Europe
Skyrizi
ulcerative colitis
AbbVie's Q2 Earnings Beat Estimates, Raises Annual Profit On Strong Sales From Newer Immunology And Cancer Drugs
Yahoo/Benzinga
Thu, 07/25/24 - 11:30 am
AbbVie
earnings
AbbVie axes midstage Alzheimer's program amid 'evolving landscape'
Fierce Biotech
Thu, 07/25/24 - 11:30 am
AbbVie
Alzheimer's disease
ABBV-916
Sionna revives AbbVie’s cystic fibrosis drugs, eyeing a shot at Vertex
BioPharma Dive
Tue, 07/16/24 - 12:06 pm
Sionna Therapeutics
cystic fibrosis
AbbVie
Vertex Pharmaceuticals
5 Neuro Data Readouts to Watch in the Second Half of 2024
BioSpace
Mon, 07/15/24 - 11:43 am
neurology
clinical trials
Athira Pharma
fosgonimeton
Alzheimer's disease
AbbVie
Cerevel Therapeutics
emraclidine
schizophrenia
Neumora Therapeutics
major depressive disorder
navacaprant
Amylx
AMX003
Wolfram syndrome
Vigil Neuroscience
iluzanebart
AbbVie led the way in paying doctors to pitch its drugs last year
Axios
Mon, 07/15/24 - 09:57 am
AbbVie
physician payments
AbbVie Submits Applications for Rinvoq for Giant Cell Arteritis
Managed Healthcare Executive
Sun, 07/14/24 - 10:12 pm
AbbVie
Rinvoq
FDA
EMA
giant cell arteritis
AbbVie’s Humira continues to lose market share as biosimilars gain ground
BioSpace
Fri, 07/12/24 - 11:35 am
AbbVie
Humira
biosimilars
AbbVie asks Supreme Court to uphold attorney-client privilege in AndroGel lawsuit
Fierce Pharma
Thu, 07/11/24 - 11:02 pm
AbbVie
Androgel
legal
Supreme Court
generics
Don’t call it a comeback: Biotech’s CNS resurgence forges Big Pharma connections
Pharma Voice
Fri, 06/28/24 - 11:17 am
Big Pharma
Neuroscience
Prothena Biosciences
Biogen
Eisai
Pfizer
AbbVie
Eli Lilly
Bristol Myers Squibb
AbbVie sweeps up inflammatory-focused Celsius for $250M cash in summer heat wave
Fierce Biotech
Thu, 06/27/24 - 11:27 am
AbbVie
M&A
Celsius Therapeutics
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »